Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EJ6795 / 1||- / OT|
Administered by: Other Purchased by: ??
Symptoms: Alanine aminotransferase, Aspartate aminotransferase, Blood albumin, Blood alkaline phosphatase, Blood calcium, Blood chloride, Blood creatinine, Blood gases, Blood glucose, Blood potassium, Blood sodium, Blood urea, C-reactive protein increased, Coma, Gamma-glutamyltransferase, Glomerular filtration rate, Haemoglobin, Heart rate, Hypoxia, Neutrophil count, Oxygen saturation, PCO2, Platelet count, PO2, Prothrombin time, Quadriplegia, White blood cell count, Protein total, Lipase, Brain natriuretic peptide, Antidepressant drug level, Troponin, Coma scale, Blood pressure measurement
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:
Write-up: Coma; Hypoxia/Severe hypoxia (O2 Sat 63%); flaccid quadriplegia; This is a spontaneous report downloaded from the Regulatory Authority, regulatory authority report number: FR-AFSSAPS-BX20211195. A contactable physician reported that an 88-year-old female patient received bnt162b2 (COMIRNATY solution for injection; lot number: EJ6795; expiry date: unknown) intramuscular on 02Feb2021 at 14:30, at a single dose, for COVID-19 immunisation. Medical history included hypertension arterial, embolism pulmonary, uterine cancer NOS, atrial fibrillation, and osteoporosis. Patient with an extensive history including meningoencephalitis in 2002 with hippocampal involvement, advanced cognitive disorders, assistance requried in all daily activities, patient communicating with slate, with a deterioration of the general condition for several days. Concomitant medication included clotiazepam (VERATRAN), lercanidipine hydrochloride (LERCAN), gabapentin (NEURONTIN), ferrous fumarate (FUMAFER), levothyroxine sodium (LEVOTHYROX), rivaroxaban (XARELTO), colecalciferol (UVEDOSE), valsartan (TAREG), calcium carbonate (CALCIDOSE), and pantoprazole. The morning of the vaccination, apathetic patient, found slumped on the right side with a doubt of a facial paralysis, but with responses to simple orders, without sensory-motor deficit or frank facial paralysis demonstrated by the nurse. No notion of choking in the last few days. Vaccination at 2:30 p.m., mention of the lack of immediate effect on the report. The patient experienced severe hypoxia (O2 Sat 63%) and unfavorable coma after vaccination, cause of death not found. According to the declarant, 20 minutes after vaccination, sudden desaturation (Sat O2 63%) with hypovigilance increasing to coma, flaccid quadriplegia observed during transport. Arrival at emergency at 3:54 p.m., GCS 3, TA 170/70 mmHg, HR 80 bpm, blood glucose 10 mmol / l, 98% saturation under 9L of oxygen, auscultation with symmetrically reduced mV, breathing through the mouth, absence of polypnea, abdomen supple without guarding. Neurological examination with flaccid quadriplegia, no ROT, reactive symmetrical pupils, (suspicion of anisocoria), suspicion of right facial paralysis. Biological Examination were as follows: Blood gas: pH 7,11 - PO2 232 - PCO2 131. NF with leucoytes 10.4 G / L, PNN 8.4 G / L, Hb 16.4 g / l, platelets 331 G / L, PT 52%, TCA 40, CRP 0,8, Na + 141 mmol / l, K + 5 mmol / l, Ca 2.37, Cl 99 mmol / l, creatinine 45 micromol / l, DFG 95 ml / min, Urea 9.9 mmol / l, protein 69 g / L, albumin 37 g, ASAT 25, ALAT 30, GammaGT 13, PAL 103, Lipase 35, fasting blood sugar, 1.56 g / l, troponin 10.9 (without further details), BNP 56, Other explorations: RSR ECG, no polarization disorder, brain MRI: no stroke, sequelae of old stroke, no bleeding. Development: With regard to the general condition and risk of death, decision on comfort care after collegial discussion. In the hypothesis of an aa status epilepticus, treatment with levetiracetam 3.5 g slow IV, no improvement. Treatment with morphine and midazolam in the face of pain and polypnea facies (40 rpm). Death noted at 10:30 am the next day (03Feb2021). Autopsy information was unknown. Details of treatment, pre-vaccination context, exploratory workup and death, cause of death and date. N.B.: Accountability "without prejudice to elements of investigations that might be performed for legal or indemnity purposes." No follow-up attempts are possible. No further information expected.; Reported Cause(s) of Death: Death; Hypoxia/Severe hypoxia (O2 Sat 63%); flaccid quadriplegia
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166